OM
Oldakowski Mark
首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Oldakowski Mark, 首席执行官. Officer active across 3 companies, notably Bionano Genomics, Inc. In total, 14 reports have been recorded. Activity tracked since 12 May 2021. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Oldakowski Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
27 股@ US$1.300.0002% mcap0.0% 占其流量Common StockSEC:0001745566-26-000006:0
20 股@ US$1.100.0% 占其流量Common StockSEC:0001745566-26-000004:0
59 股@ US$4.060.2% 占其流量Common StockSEC:0001745566-25-000007:0
59 股@ US$4.060.2% 占其流量Common StockSEC:0001745566-25-000005:0
27 股@ US$3.690.1% 占其流量Common StockSEC:0001411690-25-000056:0
20 股@ US$5.730.1% 占其流量Common StockSEC:0001411690-25-000019:0
3,568 股@ US$0.481.8% 占其流量Common StockSEC:0001411690-24-000053:0
16,000 股0Common StockSEC:0001415889-24-015624:0
1,229 股@ US$1.271.7% 占其流量Common StockSEC:0001415889-24-006810:0
20,000 股0Common StockSEC:0001209191-23-050186:0
41,496 股@ US$0.6629.7% 占其流量Common StockSEC:0001411690-23-000030:0
120,000 股0Common StockSEC:0001209191-23-010920:0
41,496 股@ US$1.410.34% mcap100.0% 占其流量Common StockSEC:0001209191-22-029458:0
240,000 股0Common StockSEC:0001209191-21-032932:0
About Oldakowski Mark
Mark Oldakowski is Directeur Général. He has 14 filings, and across the 14 sampled filings between 2021-05-14 and 2026-06-03, the modal transaction nature is tax withholding, with sum_buy_eur at 0 and sum_sell_eur at 0.